Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Prothena by 7.5% in the 4th quarter.
The impact that Dunn could have on the regulatory submission process for PRX012, or any other Prothena drug, is potentially invaluable.